L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension

Last updated: August 23, 2018
Sponsor: Sherief Abd-Elsalam
Overall Status: Active - Recruiting

Phase

4

Condition

Williams Syndrome

Circulation Disorders

Stress

Treatment

N/A

Clinical Study ID

NCT03402191
Prof Elshanshoury
  • Ages 6-18
  • All Genders

Study Summary

This study compares L-arginine Versus Sildenafil as treatment for pulmonary hypertension in Children with Beta Thalassemia

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Children with thalassemia and pulmonary hypertension.

Exclusion

Exclusion Criteria:

  • Rheumatic heart diseases.

  • Other comorbid disease

Study Design

Total Participants: 60
Study Start date:
July 01, 2016
Estimated Completion Date:
December 31, 2023

Study Description

This study focuses on different lines of treatment for pulmonary hypertension in children with thalassemia as this study discusses the Effect of L-arginine Versus Sildenafil in Children with Beta Thalassemia Associated with Pulmonary Hypertension

Connect with a study center

  • Sherief Abd-Elsalam

    Tanta,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.